-
1 Comment
Inogen, Inc is currently in a long term uptrend where the price is trading 37.6% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.7.
Inogen, Inc's total revenue sank by 6.3% to $74M since the same quarter in the previous year.
Its net income has dropped by 272.4% to $-5M since the same quarter in the previous year.
Finally, its free cash flow grew by 41.5% to $10M since the same quarter in the previous year.
Based on the above factors, Inogen, Inc gets an overall score of 3/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
ISIN | US45780L1044 |
Sector | Healthcare |
Industry | Medical Devices |
Market Cap | 163M |
---|---|
PE Ratio | None |
Target Price | 71 |
Beta | 1.49 |
Dividend Yield | None |
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 6IO.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025